Research Article

LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson’s Disease Cohort from Kazakhstan

Table 6

Studies investigating LRRK2 p.Gly2385Arg variant in Asian populations.

CasesControlsEthnicityORMAF for PD patients

Funayama et al., 2007 [13]448/52 (11.6%) (2 homozygous cases)457/22 (4.8%)JapaneseOR for the frequency of A allele 2.63, 95% CI: 1.56–4.35,  = 1.24 × 10−40.06
Di Fonzo at al., 2006 [6]608/61 (10%)373/18 (4.8%)Han Chinese from TaiwanOR = 2.24, 95% CI: 1.29–3.88, p = 0.0040.05
Fung et al., 2006 [17]305/27 (9%)176/1 (0.5%)Han Chinese from Taiwan16.99, 95% CI: 2.29 to 126.21, 0.4 No positive cases with FH
An et al., 2008 [21]600/71 (1 homozygous) (11.9%)334/11 (3.3%)Han ChineseOR 3.9, 95% CI = 2.1–7.5, 0.06
Tan et al., 2007 [18]494/37 (7.27%) (1 homozygous)495/18 (3.64%)Ethnic ChineseOR 2.1, 95% CI: 1.1–3.9, PAR of 4% for the Gly2385Arg heterozygous genotype.
Tan et al., 2007 [8]166/2 (Malays)306/2 (Malays)Malay 98/173, Indian ethnicity 66/133OR 2.83, 95% CI 0.40, 20.2, 0.003 for Malays
Farrer et al., 2007 [16]410/34335/13 (3.9%)Ethnic ChineseOR 2.24 95% CI 1.16–4.32, MAF 0.08
23.1% (n = 6/26) of patients with familial parkinsonism.
Ross et al., 2011 [23]1,376962Japan, Korea, TaiwanOR: 1.73, 95% CI: 1.20–2.49, MAF 3.3%
Japan
PD: 173
Control: 75
Korea
|PD: 844
Control: 587
Taiwan
PD: 369
Control: 300
Mata et al., 2005 [20]100 probands with PD FH/2 casesTaiwan1 family with 2 members
Zabetian et al., 2009 [24]601/69 (11.5%)1628/101 (6.2%)JapaneseOR, 1.83; 95% CI: 1.31–2.54;  = 3.3 × 10−4
Gapalai et al., 2015 [14]695507MalaysianOR 2.22 ()MAF = 0.026

OR–odds ratio, MAF–minor allele frequency, PAR–population attributable risk, and FH–family history.